PBM:US
$4.91
-5.937%
Psyence Biomedical Ltd.Insider Activity
Last updated: Jun 2, 2025, 1:03 AM ET
Profile
Company Description
Psyence Biomedical Ltd. (Nasdaq: PBM) is the world's first life science biotechnology company focused on the development of botanical (nature derived, or non-synthetic) psilocybin-based psychedelic medicine to be listed on Nasdaq. The name 'Psyence' combines the words 'psychedelics' and 'science' to affirm Psyence Biomed's commitment to an evidence-based approach to innovation as it works to develop safe and effective, nature-derived psychedelic therapeutics to treat a broad range of mental health disorders. The Company is initially focused on mental health disorders in the context of Palliative Care.